U.S. federal trademark · Serial No. 85510329
Pharmaceutical preparations for the modulation of GABA receptors; pharmaceutical preparations for anesthesia and anesthetic purposes for surgical and non-surgical use; pharmaceutical preparations for sedation and sedative purposes for surgical and non-surgical use; pharmaceutical preparations for antiemesis and antiemetic purposes for surgical and non-surgical use; pharmaceutical preparations for the prevention, treatment, and management of pain, addiction withdrawal, anxiety, insomnia, migraines, nausea, vomiting, neurodegenerative conditions of the nervous system, seizures, trauma to the central nervous system, free radical-associated diseases and disorders, attention deficit hyperactivity disorder, chronic fatigue syndrome, brain injury, narcolepsy, and obesity; pharmaceutical preparations, namely, prodrugs used to deliver drugs in a manner that provides a modified PK profile, tamper resistance, abuse resistance, and overdose protection
Research and development in the pharmaceutical and biotechnology fields; consulting services in the field of pharmaceutical and biotechnology research and development
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.